Private Capital Group’s BeOne Medicines Ltd ONC Stock Holding History

Private Capital Group’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$43K	Hold	264	–	–	0.03%	538
2022 Q1	$50K	Buy	264 +25	+10%	+$5.32K	0.01%	653
2021 Q4	$65K	Buy	239 +7	+3%	+$2.36K	0.01%	574
2021 Q3	$84K	Buy	232 +32	+16%	+$10.5K	0.02%	485
2021 Q2	$69K	Buy	200 +17	+9%	+$5.63K	0.02%	545
2021 Q1	$64K	Buy	183 +24	+15%	+$7.95K	0.02%	534
2020 Q4	$41K	Buy	159 +10	+7%	+$2.75K	0.01%	890
2020 Q3	$43K	Buy	149 +5	+3%	+$1.18K	0.01%	794
2020 Q2	$27K	Hold	144	–	–	0.01%	985
2020 Q1	$18K	Sell	144 -2	-1%	-$313	﹤0.01%	1069
2019 Q4	$24K	Hold	146	–	–	0.01%	1042
2019 Q3	$18K	Buy	+146	New	+$19.4K	﹤0.01%	1244
2019 Q2	–	Sell	-148	Closed	-$20K	–	2442
2019 Q1	$20K	Buy	+148	New	+$20K	﹤0.01%	1213

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Private Capital Group's ONC Position: Q2 2022 in Review

Private Capital Group held its BeOne Medicines Ltd (ONC) position steady in Q2 2022 at 264 shares worth $43K. The position accounts for 0.03% of the portfolio, ranked #538.

Private Capital Group first reported a position in ONC in Q1 2019 and has held it in 13 quarters since. The position peaked at $84K in Q3 2021. 235 funds tracked by Wall St. Rank hold ONC as of Q2 2022.

Private Capital Group held 264 shares of BeOne Medicines Ltd worth $43K as of Q2 2022.
Private Capital Group left its BeOne Medicines Ltd share count unchanged in Q2 2022.
BeOne Medicines Ltd made up 0.03% of Private Capital Group's portfolio in Q2 2022, its #538 holding.
Private Capital Group first reported a position in BeOne Medicines Ltd in Q1 2019 and has held it in 13 quarters since.
Private Capital Group's BeOne Medicines Ltd position peaked at $84K in Q3 2021.
235 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.